University College London: Molecular Test Personalises Prostate Cancer Treatment
August 28, 2025
August 28, 2025
LONDON, England, Aug. 28 (TNSjou) -- The University College London issued the following news:
* * *
Molecular test personalises prostate cancer treatment
Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, according to a new study led by UCL researchers.
Published in Cel . . .
* * *
Molecular test personalises prostate cancer treatment
Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, according to a new study led by UCL researchers.
Published in Cel . . .